An overview of the active clinical trials for Parkinson’s disease psychosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An overview of the active clinical trials for Parkinson’s disease psychosis

Published:2022-08 Issue:4 Volume:12 Page:165-170
ISSN:1758-2024
Container-title:Neurodegenerative Disease Management
language:en
Short-container-title:Neurodegenerative Disease Management

Author:

Kwan Cynthia¹^ORCID,Huot Philippe¹²³^ORCID

Affiliation:

1. Neurodegenerative Disease Group, Montreal Neurological Institute-Hospital (The Neuro), Montreal, QC, H3A 2B4, Canada

2. Department of Neurology & Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada

3. Department of Neuroscience, Movement Disorder Clinic, Division of Neurology, McGill University Health Centre, Montreal, QC, H3A 2B4, Canada

Abstract

Tweetable abstract An overview of the active clinical trials for Parkinson's disease psychosis. In this article, we review the drugs currently undergoing clinical testing for Parkinson's disease psychosis and offer some perspectives on the treatment of the condition.

Publisher

Future Medicine Ltd

Subject

Neurology (clinical)

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nmt-2022-0020

Reference44 articles.

1. Sydney multicenter study of Parkinson's disease: Non‐ L ‐dopa–responsive problems dominate at 15 years

2. Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial

3. Difficult choices in treating Parkinson's disease psychosis

4. Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

5. Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United States

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP